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Golgi-associated LC3 lipidation requires V-ATPase in
noncanonical autophagy
Ying Gao1,5, Yajun Liu1,5, Liang Hong1, Zuolong Yang1, Xinran Cai1, Xiaoyun Chen2, Yuanyuan Fu1, Yujie Lin1, Weijie Wen1, Sitong Li1,
Xingguo Liu3, Heqing Huang1, Andreas Vogt4, Peiqing Liu*,1, Xiao-Ming Yin*,2 and Min Li*,1
Autophagy is an evolutionarily conserved catabolic process by which cells degrade intracellular proteins and organelles in the
lysosomes. Canonical autophagy requires all autophagy proteins (ATGs), whereas noncanonical autophagy is activated by diverse
agents in which some of the essential autophagy proteins are dispensable. How noncanonical autophagy is induced and/or
inhibited is still largely unclear. In this study, we demonstrated that AMDE-1, a recently identified chemical that can induce
canonical autophagy, was able to elicit noncanonical autophagy that is independent of the ULK1 (unc-51-like kinase 1) complex
and the Beclin1 complex. AMDE-1-induced noncanonical autophagy could be specifically suppressed by various V-ATPase
(vacuolar-type H+-ATPase) inhibitors, but not by disturbance of the lysosome function or the intracellular ion redistribution. Similar
findings were applicable to a diverse group of stimuli that can induce noncanonical autophagy in a FIP200-independent manner.
AMDE-1-induced LC3 lipidation was colocalized with the Golgi complex, and was inhibited by the disturbance of Golgi complex.
The integrity of the Golgi complex was also required for multiple other agents to stimulate noncanonical LC3 lipidation. These
results suggest that the Golgi complex may serve as a membrane platform for noncanonical autophagy where V-ATPase is a key
player. V-ATPase inhibitors could be useful tools for studying noncanonical autophagy.
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Macroautophagy (hereafter referred to as ‘autophagy’) is
an evolutionarily conserved process that degrades damaged
organelles or long-lived proteins and relies on lysosome
system to provide nutrients under conditions of metabolic
stress. Disturbance of autophagy has been identified in
various human disease such as neurodegenerative disease,
infectious disease and cancer.1,2
Autophagy could be mediated by a number of proteins
encoded by autophagy-related genes (Atgs). Key ATG
molecules are involved in four distinct steps of autophago-
some formation andmaturation, that is, nucleation, elongation,
maturation and fusion.3 The nucleation is often initiated by the
ULK1 (unc-51-like kinase 1) complex, which includes ULK1,
FIP200 and ATG13, and by the autophagy-specific Beclin1
complex, which includes Beclin1, ATG14 and the class III
phosphatidylinositol-3 kinase (PI3KC3). These complexes
are activated or inhibited by upstream signals, such as those
mediated by the mTORC1 and the AMPK pathways.4 The
initial autophagosomal membranes can be derived from
a variety of different sources, which nucleates to form the
phagophore with the activation of the above two complexes.5
The elongation and maturation of autophagosomal mem-
branes relies on the conjugation systems involving ATG7,
ATG12, ATG5, ATG16, ATG10 and ATG3, and eventually
yields phosphatidylethanolamine-conjugated LC3 and other
ATG8 family members. Finally, the matured autophagosome
will fuse with the lysosome for cargo degradation. These steps
are known to be essential for the canonical autophagy.
The noncanonical autophagy (NCA) is generally referred to
the process that can bypass the involvement of ULK1 and/or
Beclin1 complex.6–8 Although an ATG7/ATG5-independent
pathway has been reported.9,10 NCA is in general classified
as a process dependent on the conjugation system and is
characterized by LC3 lipidation. NCA has been identified in
various settings. NCA was first found to be independent of the
Beclin1 complex.6,8,11 More recently, proapoptotic compounds
such as MK801, gossypol and proteasome inhibitors MG132
and bortezomib have been found to induce Beclin1-inde-
pendent autophagy.12 Autophagy response independent
of the ULK1 complex has been reported in response to
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ammonia,13 cis-unsaturated fatty acids14 and glucose
deprivation.13,15
NCA may represent a variety of different LC3-positive
structures, including double-membrane autophagosome (by
EM), autophagosome-like structure (by GFP-LC3 dots only),
noncanonical LC3 lipidation (by western blot assay only) and
LAP (LC3-associated phagocytosis, by GFP-LC3 dots).16,17
LAP may be a special form of NCA but has connections
with host autophagic responses in terms of microbial
infection.16 NCA structures with either single or double
membranes have the same function as the canonical
autophagy in sequestering cytoplasm and compartmentaliz-
ing invading pathogens, which are ultimately degraded in the
lysosomal compartment.7
The function of NCA is not very clear in every case.
However, some processes such as entosis and LAP have
been well studied,18–20 suggesting that the noncanonical
functions of ATG molecules have important physiological
functions. Phagocytosis of live or dead cells or pathogens can
be facilitated by the LC3-positive compartment.20,21 In
addition, chemical-induced NCA or noncanonical LC3 lipida-
tion has been reported to be positively correlated with human
tumor cell death8,22 and resistance to pathogens.23 It is
possible that cells lacking ULK1 or Beclin1 activity, or with a
low autophagy-initiating capability might evolve to use NCA as
a way to resist pathogen invasion or to survive in adverse
environments. NCA might be either an important complemen-
tary mechanism or a parallel system for the regulation of a list
of pathophysiological processes.
HowNCA is activated is not well understood in many cases,
which hampers the understanding of the function of NCA and
its relationship with canonical autophagy. AMDE-1 is a novel
chemical that can trigger canonical autophagy.24 In this study,
we demonstrated that AMDE-1 can also induce NCA, which
depends on vacuolar-type H+-ATPase (V-ATPase) and an
integrated Golgi complex. Furthermore, we showed that these
requirements were generally needed for NCA induced by
several other agents, thus revealing a potentially general
mechanism for a diverse set of NCA stimuli.
Results
AMDE-1-triggered autophagy is independent of the ULK1
complex but dependent on ubiquitin-like conjugation
systems. AMDE-1 was found through high-content screen-
ing using GFP-LC3.24 It is a novel autophagic modulator that
can initiate canonical autophagy at the early stage via
suppression of mTORC1. We used MEFs deficient in
FIP200 or ULK1 to investigate the role of the ULK1 complex
in AMDE-1-induced autophagy. Surprisingly, AMDE-1 still
induced LC3-II formation in FIP200KO-MEF and in ULK1KO-
MEF (Figure 1a). The kinetics of AMDE-1-induced LC3-II
formation in FIP200KO-MEF was the same as that in
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Figure 1 AMDE-1 can induce NCA, which is independent of FIP200 and ULK1 but dependent on the conjugation system. (a) Wild- type MEFs (WT), FIP200KO-MEFs (FIP),
ULK1KO-MEFs (ULK) and Atg5KO-MEFs (Atg5) were treated with AMDE-1 (10 μM) for 6 h, or EBSS for 2 h, and then analyzed by immunoblotting. (b) Immunoblotting analysis
of WT-MEFs and FIP200KO-MEFs treated by AMDE-1 (10 μM) at different time points. (c) WT-MEFs, FIP200KO-MEFs, ULK1KO-MEFs and Atg5KO-MEFs expressing GFP-LC3
were treated with or without AMDE-1 (10 μM) for 6 h, or EBSS for 2 h and then assessed for LC3 puncta formation (green). (d) Qualification of GFP-LC3 puncta in (c).
(e) FIP200KO-MEFs expressing GFP-LC3G120A were treated with or without AMDE-1 (10 μM) for 6 h and then assessed for LC3 puncta formation (green). ***Po0.001;
NS, not significant. Bar= 25 μm
Noncanonical autophagy requires V-ATPase
Y Gao et al
2
Cell Death and Disease
WT-MEF (Figure 1b). The number of GFP-LC3 puncta in
FIP200KO-MEF and in ULK1KO-MEF was reduced but
remained significant following AMDE-1 stimulation (Figures
1c and d). When GFP-LC3G120A was applied, which is
defective for LC3 lipidation, no obvious GFP puncta were
elicited after treatment (Figure 1e), suggesting that AMDE-1-
induced GFP puncta in FIP200KO-MEF involved the lipida-
tion of GFP-LC3.
Nevertheless, AMDE-1-induced LC3 lipidation required the
canonical conjugation systems. Thus, there was no LC3-II
formation (Figure 1a) nor GFP-LC3 puncta (Figure 1c and d) in
Atg5KO-MEF following the treatment with AMDE-1. Consis-
tently, Atg7, Atg4B and Atg3 were all required for AMDE-1-
induced LC3 lipidation (Supplementary Figure S1). Taken
together, these data indicated that AMDE-1 was able to trigger
NCA in FIP200KO and ULK1KO cells, which was dependent
on the ubiquitin-like conjugation systems.
AMDE-1-induced autophagy does not require Beclin1
complex. To evaluate whether the observed LC3 lipidation
was initiated via Beclin1 complex, we used PI3KC3 inhibitors
3-methyladenine (3-MA) and wortmannin (WM) and found
that LC3 lipidation could not be suppressed by these cano-
nical autophagy inhibitors (Figure 2a). We further checked
the formation of Atg16 puncta, a critical event that occurs
earlier than LC3 lipidation. As shown in Figure 2b, rapamycin
induced strong Atg16 punctuation, which was totally sup-
pressed by a PI3KC3 inhibitor 3-MA, whereas AMDE-1-
induced Atg16 puncta failed to be suppressed by 3-MA.
Atg14 is an important component that bridges Beclin1
and Vps34 to allow formation of Beclin1 complex.25 Similar
to the pattern of PI3KC3 inhibition, knockdown (KD) of
Atg14 could not impair the formation of LC3-II induced by
AMDE-1 (Figure 2c). Finally, we found that there was
no difference in LC3-II conversion and GFP-LC3 puncta
formation between wild-type U251 cells and U251 cells
with constitutive Beclin1 KD (Figure 2d and e). These data
suggested that Beclin1 complex was not required for
AMDE-1-induced NCA.
AMDE-1 does not recruit WIPI2 but does recruit
Atg16 and Atg12. WIPI2, a phosphoinositide-interacting
protein with WD repeat domain, and DFCP1, a double
FYVE-containing protein 1, were monitored to confirm the
initiation of autophagy. WIPI2 forms a complex with ATG2 and
functions in autophagosome formation in a phosphatidyl-
inositol-3-phosphate (PI3P)-dependent manner, perhaps by
recruiting ATG16 for LC3 lipidation.26 In the absence of
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Figure 2 AMDE-1-induced NCA does not require the participation of the canonical autophagy-specific class III PI-3 kinase. (a) WT-MEFs were treated by AMDE-1 (10 μM)
with or without 3-MA (10 mM) or WM (1 μM) for 6 h, and then analyzed by immunoblotting. (b) A549 cells were treated as indicated (Rap, 1 μM; AMDE-1, 10 μM; 3-MA, 10 mM)
for 6 h, followed by immunostaining with an anti-ATG16L1 antibody. Arrows indicate ATG16-positive dots. (c) Atg14-siRNA was transfected to wild- type MEFs for 48 h, followed by
treatment with AMDE-1 or EBSS. (d and e) Wild-type and Beclin1 KD U251 cells expressing GFP-LC3 were treated with or without AMDE-1 (10 μM) for 6 h or EBSS for 2 h and
then assessed for LC3-II formation by immunoblotting (d), or immunostaining (e). Bar= 25 μm
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FIP200, there was no WIPI2 puncta formed following either
rapamycin or AMDE-1 treatment (Figure 3a), and there
was no DFCP1-positive structures as well (Supplementary
Figure S2), suggesting that WIPI2 and DFCP1 were strictly
regulated by ULK1 complex and was recruited by AMDE-1.
The data also suggested that WIPI2 and DFCP1 could be
dispensable in AMDE-1-induced NCA.
On the contrary, both rapamycin and AMDE-1 induced
ATG16 puncta in wild-type MEFs, but such puncta could be
induced only by AMDE-1 in FIP200KO-MEFs (Figure 3b).
Staining for ATG12-positive structures showed that the staining
pattern was similar to that of ATG16 (Figure 3c). ATG12-positive
dots in FIP200KO-MEF was not suppressed by 3-MA. We then
compared the distribution of ATG12- and ATG16-positive dots,
and the conjugation of ATG5–ATG12 after AMDE-1 treatment.
Nearly 100% of ATG12 dots were colocalized with ATG16
dots (Figure 3d). ATG12–ATG5 conjugation was not affected
(Supplementary Figure S3), suggesting that the integrity of
ATG5–12/16 complex remained in AMDE-1 treatment. These
data suggested that AMDE-1 could recruit the ATG5–12/16
complex to a membrane platform for NCA via a mechanism
independent of WIPI2 and/or DFCP1.
Bafilomycin blocks AMDE-1-induced NCA. We found that
a commonly used autophagy degradation inhibitor, bafilo-
mycin A1 (Baf), was able to inhibit AMDE-1 induced LC3
lipidation in FIP200KO-MEFs (Figures 4a and b). In wild-type
MEFs, Baf alone was able to reduce AMDE-1 induced LC3-II
formation (Figure 4c). Notably, the combination of 3-MA and
Baf almost completely repressed LC3-II formation (Figure 4d)
and GFP-LC3 puncta (Figure 4e) in wild-type MEF. These
data indicated that AMDE-1 induced autophagy in wild-type
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Figure 3 AMDE-1-induced NCA does not recruit WIPI2, but Atg16 and Atg12. (a) WT-MEFs and FIP200KO-MEFs were treated with or without AMDE-1 (10 μM) or
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Figure 4 AMDE-1-induced NCA can be suppressed by Baf. (a) FIP200KO MEFs were treated with or without AMDE-1 (10 μM), Rap (1 μM) and/or Baf (0.5 μM) for 6 h, and
then analyzed by immunoblotting. (b) FIP200KO MEFs expressing GFP-LC3 were treated as indicated (AMDE-1, 10 μM; Baf, 0.5 μM) for 6 h, and then assessed for LC3 puncta
formation. (c and d) Wild-type MEFs were treated as indicated (AMDE-1, 10 μM; Rap, 1 μM; 3-MA, 10 mM; Baf, 0.5 μM) for 6 h, and then analyzed by immunoblotting.
The LC3-II/Tubulin ratio was calculated relative to that of control medium (CM). (e) Wild-type MEFs expressing GFP-LC3 were treated as indicated (AMDE-1, 10 μM; 3-MA,
10 mM; Baf, 0.5 μM) for 6 h, and then assessed for LC3 puncta formation. (f) FIP200KO-MEFs expressing GFP-LC3 were treated by AMDE-1 (10 μM) with or without
Baf (0.5 μM) for 6 h, followed by immunostaining of SQSTM1. Arrows indicate the examples of colocalized puncta of GFP-LC3 and SQSTM1. Bar= 25 μm. **Po0.01;
***Po0.001
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MEF could be caused by two different mechanisms, one was
for canonical autophagy, which was inhibited by 3-MA, and
the other was for NCA, which was suppressed by Baf.
SQSTM1/p62 is a multifunctional adaptor protein that
recruits ubiquitinated protein substrates to LC3 for autophagic
degradation.27 The puncta of SQSTM1 increased markedly in
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response to AMDE-1 in FIP200KO-MEF, in which SQSTM1
overlapped with LC3 nearly completely (Figure 4f). In line with
the fate of LC3 puncta, the accumulated SQSTM1 puncta
were abolished by Baf as well (Figure 4f). Such AMDE-1-
induced colocalization also occurred in HeLa cells even
in the presence of 3-MA (Supplementary Figure S4). To
investigate whether SQSTM1 was involved in LC3 lipidation,
we knocked it down and found reduction of SQSTM1 could
not decrease the overall number of LC3 puncta, and the
LC3-II level induced by AMDE-1, regardless of the presence of
3-MA (Supplementary Figure S4). These data thus indicated
that SQSTM1 was not required for AMDE-1-induced LC3
lipidation.
V-ATPase inhibitors instead of lysosome inhibitors and
ionophores block LC3 lipidation. Similar to Baf, concana-
mycin A (ConA) is a well-studied V-ATPase inhibitor.
Salicylihalamide A (SalA) is another mammalian-specific
V-ATPase inhibitor, but has a distinct binding pattern
compared with Baf and ConA.28 Similar to Baf, both ConA
and SalA suppressed AMDE-1-induced LC3-II significantly in
FIP200KO-MEF at the dose from 1 to 100 nM (Figures 5a–c),
which indicated that V-ATPase was a critical molecule for
NCA and the inhibitory effect of NCA by Baf was indeed
targeted toward this molecule.
V-ATPase is significantly present in the lysosomal mem-
brane and is responsible for the acidic environment of the
lysosome. In fact, Baf is often used to disrupt autophagic and
non-autophagic lysosomal degradation through its inhibition
on lysosomal V-ATPase.29 To determine whether the lyso-
some acidic or proteolytic environment was required for
AMDE-1-induced NCA, we assessed other well-known
lysosome inhibitors, including chloroquine (CQ), ammonia
chloride, and protease inhibitors E64d and pepstatin A. We
found that none of these chemicals could suppress AMDE-1-
inducedNCA based on the results of immunoblotting for LC3-II
(Figure 5d) and immunostaining for ATG12 puncta (Figure 5e).
These observations suggested that lysosome V-ATPase could
be affected by Baf, ConA or SalA, but lysosomal functional
change might not be the cause leading to NCA in AMDE-1
treatment.
In addition, Baf has been reported to have the activity as
a K+ ionophore.30 To determine whether redistribution of
intracellular ions has a general impact on AMDE-1-induced
NCA, we assessed the effects of several ionophores, including
monensin (for Na+), nigericin (for K+), valinomycin (for K+),
gramicidin A (for monovalent cations), ionomycin (for Ca2+)
and A23187 (for Ca2+). The results indicated that these
chemicals did not block AMDE-1-induced LC3 lipidation
(Figures 5f–g).
Functional V-ATPase is required for noncanonical LC3
lipidation. NCA could be induced by a variety of chemicals.12
Recently, chemicals such as proteasome inhibitors (MG132,
bortezomib and lactacystin), ammonia, gossypol and CQ
were reported to promote the lipidation of LC3 in a ULK1-
independent or Beclin1-independent manner.12,31 Whether
these chemicals had any characteristics in common in
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regulating noncanonical LC3 lipidation processes was
unknown. We found Baf impaired LC3 lipidation caused by
these chemicals (Figures 6a–f). Furthermore, unsaturated fatty
acids, glucose deprivation and osmotic imbalance were also
reported to induce NCA.13,14,31 We found that Baf inhibited
LC3 lipidation in FIP200KO cells cultured with solium oleate, in
low glucose medium or in hypotonic medium (Figures 6g–i).
These data suggested that V-ATPase could mediate a
mechanism for NCA common to many different stimuli.
V-ATPase-positive Golgi complex is involved in LC3
lipidation. As Baf and other V-ATPase inhibitors did not
seem to act upon the lysosome for its inhibition of NCA, their
effect on NCA might involve other intracellular membrane
compartments where V-ATPase is present. To determine
potential contributions of these compartments to AMDE-1-
induced NCA, we first assessed whether AMDE-1-induced
LC3 puncta would be colocalized with these subcellular
organelles in FIP200KO-MEFs. As shown in Figure 7a,
AMDE-1-induced LC3-positive structures did not overlap with
the mitochondria marker Tom20, the lysosome marker LAMP1
and the ER marker ERtracker, but were juxtaposed to the ER
to Golgi intermediate compartment marker, ERGIC-53. Inter-
estingly, most of the LC3 puncta were significantly overlapped
with the cis-Golgi matrix marker GM130 and the trans-Golgi
membrane marker β-1, 4-galactosyltransferase (GALT), and
partially colocalized with trans-Golgi network marker, TGN38
(Figure 7b), suggesting that Golgi complex might be the main
membrane platform for AMDE-1-induced LC3 lipidation. Tran-
sient overexpression of V0 complex subunit c of V-ATPase,
ATP6V0c, the specific target of Baf and ConA, promoted the
colocalization of V-ATPase with LC3, and of V-ATPase with
GM130 after AMDE-1 treatments (Figure 7c). Consistently,
lysosomal inhibitors, E64D/pepstatin A (Figure 7d), or CQ
(Supplementary Figure S5), did not seem to affect the
distribution of AMDE-1-induced LC3 puncta in the Golgi
complex. E64D/pepstatin A did not cause GFP-LC3 puncta
nor did the combination suppressed AMDE-1-induced LC3
puncta (Figure 7d).
Compared with the control cells where the Golgi complex
was mostly a focal unit adjacent to the nucleus, AMDE-1
treatment seemed to disperse the Golgi complex (Figures
7b–d). Electron microscopic analysis indicated that there
were increased classical autophagosomes and autolysosome
structures (Supplementary Figure S6), and notably swollen
Golgi complex delimited by single-membrane in AMDE-1-
treated cells (Figure 7e). Furthermore, Baf did not seem to be
able to change the dispersed pattern of the Golgi complex
(Figure 7d) nor the swelling of the Golgi complex (Figure 7e) in
AMDE-1-treated cells. Thus, the V-ATPase was not likely
involved in the structural alteration of the Golgi complex, but
was likely involved in a separate step of recruitment of LC3 to
the Golgi membranes.
An integrated Golgi complex is required for AMDE-1-
induced LC3 lipidation. It is possible that an integrated Golgi
complex may actually be required for AMDE-1 to induce
noncanonical LC3 lipidation. To test this hypothesis, we used
two well-established Golgi toxins, brefeldin A (BFA) and
golgicide A (GCA). Both are known to inhibit ER to Golgi
vesicle trafficking and to fragment the Golgi complex.32 We
found that BFA and GCA not only weakened the staining signal
of Golgi complex (Figure 8a) but also abolished AMDE-1-
induced LC3 puncta and LC3-II formation (Figures 8a–c).
Consistently, SQSTM1, which were recruited by LC3 following
AMDE-1 treatment (Figure 4 and Supplementary Figure S4),
failed to accumulate in the presence of BFA (Figure 8d),
suggesting that the Golgi complex was an important platform
for AMDE-1-induced LC3 lipidation and SQSTM1 recruitment.
We then asked whether the Golgi toxin could suppress NCA
caused by other stimuli. Indeed, GCA suppressed LC3-II
formation in FIP200KO cells induced by CQ, sodium oleate,
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Figure 6 Baf can inhibit NCA induced by multiple agents. Immunoblotting analysis of FIP200KO-MEFs treated with MG132 (5 μM) for 12 h (MG, a), bortezomib (30 nM) for
12 h (BZ, b), lactacystin (5 μM) for 12 h (Lac, c), gossypol (20 μM) for 12 h (GO, d), ammonia chloride (10 mM) for 24 h (AC, e), CQ (100 μM) for 6 h (CQ, f), sodium oleate
(500 μM) for 6 h (Ole, g), glucose deprivation for 24 h (NG, h) or hypotonic buffer for 1 h (Hypo, i) with or without Baf (0.5 μM)
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Figure 7 AMDE-1-induced NCA involves the Golgi complex. (a) FIP200KO-MEFs with or without expressing GFP-LC3 were treated with AMDE-1 (10 μM) followed by
immunostaining for LC3, Tom20, ERtracker, LAMP1 or ERGIC-53. Dotted circles indicate the juxtaposed LC3 and ERGIC-53 signals. (b and c) FIP200KO-MEFs with or without
expressing mCherry-GALT, GFP-ATP6V0c and CFP-TGN38 were treated with AMDE-1 (10 μM) followed by immunostaining for LC3, or GM130. Arrows indicate colocalization of
LC3 with GM130, GALTand TGN38 (b), or ATP6V0c with LC3 or GM130 (c). (d and e) FIP200KO-MEFs were treated by AMDE-1 (10 μM) with or without Baf (0.5 μM), or E64D
(25 μM) plus pepstatin A (50 μM) for 6 h, followed by immunostaining for LC3 and GM130. Arrows indicate colocalization of LC3 with GM130 (d). Cells were also analyzed by
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AC, hypotonic buffer and three proteasome inhibitors (MG132,
bortezomib and gossypol) (Figures 8e–k). Taken together,
these observations indicated that an integrated Golgi complex
was required for many NCA stimuli to promote noncanonical
LC3 lipidation.
Discussion
Here we demonstrated that AMDE-1 was able to induce NCA,
in the absence of ULK1 complex or Beclin1/Atg14 complex. A
form of Atg7- or Atg5-independent NCA had been reported in
which LC3 lipidation did not occur.9 However, most types of
NCA including LAP still require the conjugation system and
can be detected by LC3 lipidation assay. AMDE-1-induced
NCA requires the LC3 conjugation system. SQSTM1 is an
adaptor molecule that links autophagosomal membranes to
the ubiquitinated targets to facilitate target degradation. In our
study, accumulated LC3 was overlapped with SQSTM1, but
did not depend on the latter. The colocalization of the two
molecules suggests that SQSTM1might still act as an adaptor
molecule in AMDE-1-induced NCA for target clearance.
In canonical autophagy, the ULK1 complex or the Beclin1/
Atg14 complex is required to couple the canonical autophagy
stimuli, such as amino-acid deprivation, to the generation of
PI3P on specific membranes where LC3 lipidation can
subsequently occur. Activation of NCA could be related to the
bypass of ULK1 complex for Beclin1/Atg14 activation, or be
related to the independence of LC3 lipidation on PI3P. Recently,
PI5P was found to regulate autophagy and sustain NCA in
PI3P-depleted cells.33 The importance of PI3P or PI5P
generation in autophagy may depend on the type of stimuli or
specific membranes where LC3 lipidation occurs. AMDE-1-
induced NCA can occur in the absence of ULK1 complex or the
Beclin1/Atg14 complex, suggesting that PI3P generation may
not be required. AMDE-1 might use alternative mechanisms to
activate the two ubiquitin-like conjugation systems to initiate the
NCA. This hypothesis is also implicated in the different
morphology of the ATG12 and ATG16 puncta. When rapamycin
was applied towild-type cells, ATG12 dotswere small but bright.
In contrast, AMDE-1-induced ATG12 dots looked larger but less
intensive in FIP200KO cells (Figure 3).
AsNCA represent distinct processes, themembrane sources
or the biogenesis of LC3-positive structures could be different
from those of canonical autophagy. In canonical autophagy, the
ER membrane, where the DFCP1-positive omegasome is
derived to give rise to the autophagosomes, seems to be the
major membrane source. However, the Golgi complex, mito-
chondria–ER contact sites and plasma membrane-derived
endocytic organelles can also contribute to autophagosomes
biogenesis.34 The source of membranes on which LC3
lipidation occurs could be also diverse in NCA, which can give
rise to either double- or single-membrane vesicles.7
Among the various membrane structures, the Golgi complex
deserves a particular attention as it could serve as a common
platform for canonical autophagy and NCA.35 The disruption of
Golgi complex by genetic intervention of αSNAP triggers
Beclin1-independent autophagy.36 An intact Golgi complex is
also found to be required for unsaturated fatty acid-induced
NCA.14 The structure collapse of the Golgi complex induced by
BFA inhibits cis-unsaturated fatty acid-triggered autophagy.
BFA and GCA also abolish AMDE-1-induced NCA. In addition,
AMDE-1-induced LC3 puncta are colocalized with the Golgi
complex, but not with other subcellular organelles. AMDE-1was
able to cause swelling of Golgi complex. All these data support
that AMDE-1 could target the Golgi complex where LC3
lipidation is triggered (Figure 9). Although BFA was previously
found to induce canonical autophagy in wild-type cells through
ER stress,37 we did not observe any LC3 lipidation in FIP200KO
cells treated with BFA or GCA (data not shown). Thus, these
agents cause different effects in canonical autophagy andNCA.
Lysosomes can be an important organelle promoting
NCA and where noncanonical LC3 lipidation occurs.13,14,31
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However, a diverse group of lysosome inhibitors with different
mechanisms did not affect AMDE-1-induced noncanonical
LC3-II formation (Figure 5d), GFP-LC3 punctation (Figure 7d
and Supplementary Figure S5) and Atg12 puncta formation
(Figure 5e). Although CQ alone could induce NCA13,14,31
(Figures 6f and Supplementary Figure S5), this might not
suggest that the disruption of lysosome function was sufficient
to cause NCA, as E64D/pepstatin A could not induce NCA
(Figure 7d). Notably, CQ (Supplementary Figure S5) or E64D/
pepstatin A (Figure 7d) could not inhibit AMDE-1-induced LC3
puncta and their colocalization with the Golgi complex. In
contrast, CQ-induced noncanonical LC3 puncta seemed to be
colocalized with the Golgi marker (Supplementary Figure S5).
Taken together, while the involvement of the lysosome and
other membranes in AMDE-1-induced NCA cannot be
excluded, our current data at least suggest that simply
inhibiting lysosome function may not be sufficient to inhibit
AMDE-1-induced NCA, whereas the Golgi complex could be a
common platform for noncanonical LC3 lipidation under a
variety of conditions.
The involvement of V-ATPase in NCA has been reported in a
previous study.13,14,31 Here we report that three different
inhibitors of V-ATPase, Baf, ConA and SalA, suppresses NCA
induced by AMDE-1 and several other agents, which had not
been known to depend on V-ATPase for their NCA activity. We
have further found that although V-ATPase is located at
different endosomal compartments,38 the inhibition is not likely
related to the dysfunction of the lysosome or redistribution of
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Figure 8 AMDE-1-induced NCA can be blocked by Golgi toxins. (a) FIP200KO-MEFs were treated by AMDE-1 (10 μM) with or without BFA (5 μg/ml) for 6 h, followed by
immunostaining for LC3 and GM130. Arrows indicate colocalization of LC3 with GM130. (b). FIP200KO-MEFs expressing GFP-LC3 were treated by AMDE-1 (10 μM) with or
without BFA (5 μg/ml) for 6 h, followed by immunostaining of SQSTM1. Arrows indicate colocalization of GFP-LC3 with SQSTM1. (c and d) FIP200KO-MEFs were treated by
AMDE-1 (10 μM) with or without BFA (5 μg/ml) or GCA (20 μM) for 6 h, followed by immunoblotting analysis. (e–k) Immunoblotting analysis of FIP200KO-MEFs treated with CQ
(100 μM, 6 h, e), Ole (500 μM, 6 h, f), AC (10 mM, 24 h, g), hypotonic buffer (Hypo, 1 h, h), BZ (30 nM, 12 h, i), MG132 (MG, 5 μM, 12 h, j), and GO (20 μM, 12 h, k) with or
without GCA (20 μM). Bar= 25 μm
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intracellular ions because chemicals directly disturbing these
functions have no effects on AMDE-1-induced NCA (Figure 5,
Figure 7d and Supplementary Figure S5). Our studies instead
indicate that the suppressive effect of Baf is most likely related
to Golgi-located V-ATPase, considering the involvement of the
Golgi complex in the early stage of AMDE-1-induced NCA.
Thus, AMDE-1 may act on the Golgi complex, which then
engages V-ATPase to activate the LC3 conjugation system,
leading to LC3 lipidation on the Golgi membranes (Figure 9).
There are few known inhibitors for NCA. Identification of
V-ATPase inhibitors as NCA inhibitors for a group of diverse
stimuli could facilitate the understanding of the mechanism. It
has to be pointed out that V-ATPase inhibitors, such Baf, can
be inhibitory to both canonical autophagy at the late stage and
NCA at the early stage. However, the effect on the detection of
LC3-II and LC3 puncta is different. While reducing LC3-II
and LC3 puncta in NCA, these inhibitors, such as the
traditional lysosome inhibitors, cause accumulation of LC3-II
and LC3 puncta as the results of the blockage of lysosome
degradation.1,39 Thus, V-ATPase inhibitors might be important
for dissecting signaling mechanisms through or bypass key
Atgs for stimuli, such as AMDE-1, which can cause both
canonical autophagy and NCA in the same cells. For these
stimuli, it will require the inhibition of both pathways to fully
suppress LC3 lipidation (Figures 4 and 9).
In summary, we have defined a new effect of AMDE-1 in
NCA in the absence of ULK1 complex or Beclin1 complex. The
NCA triggered by AMDE-1 requires functional V-ATPase and
an integrated Golgi complex. This seems to be a common
mechanism for a number of diverse NCA stimuli. Our finding
may provide important information on the membrane source
for, and the initiation mechanism of, the NCA.
Materials and Methods
Chemicals and antibodies. AMDE-1 was purchased from Key Organics
(Bedford, MA, USA). A23187, ammonia chloride, BFA, CQ, ConA, 3-MA, gramicidin,
monensin, valinomycin, nigericin and HgCl2 were from Sigma-Aldrich (St. Louis,
MO, USA). Baf, bortezomib and WM were from LC Laboratories (Woburn, MA,
USA). Rapamycin, E64D and pepstatin A were from AG Scientific (San Diego, CA,
USA). MG132, GCA were from Selleckchem (Houston, TX, USA). Sodium oleate
was from Sangon (Shanghai, China). Lactacystin was from Cayman (Ann Arbor,
MI, USA). Gossypol was from Meilunbio (Dalian, China). Lipofectamine 2000
was from Invitrogen (Carlsbad, CA, USA). SalA was a gift from Dr De Brabander
(UT Southwestern, Dallas, TX, USA). The siRNA for human SQSTM1/p62 (5′-GCA
TTGAAGTTGATATCGATTT-3′) and the scrambled control (5′-UUCUCCGAACGU
GUCACGU-3′) were obtained from Ruibo (Guangzhou, China).
Antibodies to ERGIC-53 (no. sc-398777), GFP (no. sc-9996) and Tom20
(no. sc-11415) were from Santa Cruz (Santa Cruz, CA, USA); antibodies to β-actin
(no. 3700), ATG3 (no. 3415), ATG12 (no. 2011S), ATG7 (no. 8558), calnexin (no.
2679) were from Cell Signaling Technology (Danvers, MA, USA); antibodies to
SQSTM1 (no. PM045), MAP1LC3B (no. PM036), ATG4B (no. M134) and ATG16L1
(no. M150) were from MBL International (Woburn, MA, USA); antibodies to ATG5
(no. A0731), LC3B (no. L7543), α-tubulin (no. T6074) were from Sigma (St. Louis,
MO, USA); antibody to WIPI2 (no. ab105459) was from Abcam (Cambridge, UK);
antibody to GM130 (no. BD-610822) was from BD Bioscience (San Jose, CA, USA);
antibody to TGN46 (no. AHP500GT) was from AbDSerotec (Oxford, UK). Secondary
antibodies conjugated with Alexa Fluor-488, Alexa Fluor-594 or horseradish peroxi-
dase (no. 7074) were from Invitrogen and Cell Signaling Technology, respectively.
Cell culture and transfection. Wild-type and ATG5- ATG3-, ATG7-, ATG4b-,
ULK1-, FIP200-deficient MEFs, A549, U251 and Beclin1 KD U251 cells had
been described previously.40,41 Cells were cultured at 37 °C in a humidified air
atmosphere with 5% (v/v) CO2. DMEM with or without glucose (Thermo Scientific,
Rockford, IL, USA) was supplemented with 10% (v/v) of fetal bovine serum (Gibico,
Grand Island, NY), USA and other standard supplements. EBSS (Thermo Scientific)
with no serum and other supplements was used as starvation medium. Hypotonic
buffer was prepared by diluting DMEM with water (water/DMEM: 3 : 1).
For transient expression, cells were cultured in 24-well plates and were transfected
with DNA constructs using Lipofectamine 2000 (Invitrogen) and analyzed 24–48 h
later. For gene KD, siRNA (120 nM) was transfected into 1 × 106 cells using
Oligofectamine (Invitrogen) for 48–72 h before analysis.
Immunoblotting assays. Cell lysates were prepared with RIPA buffer with a
protease and phosphatase inhibitor cocktail (Thermo Scientific). Twenty to thirty
micrograms of total protein were separated by SDS-PAGE and transferred to PVDF
membranes (Millipore, Billerica, MA, USA). Specific proteins were detected using
specific primary antibodies and horseradish peroxidase-conjugated secondary
antibodies, together with enhanced chemiluminescence developing agent
(Millipore). Images were digitally acquired with a Kodak Image Station 4000
(Carestream Health Inc., Rochester, NY, USA) or ImageQuant LAS 4000mini
(GE, Uppsala, Sweden), and the companion software. The density of LC3-II was
first normalized to the loading control, tubulin. Then, the ratio of LC3-II/tubulin is
converted to numbers relative to that of the control treatment.
Immunofluorescence staining. Cells were grown on 3 cm Petri dish and
were fixed in 4% paraformaldehyde for 15 min. Cells were washed two times in
phosphate-buffered saline (PBS), permeabilized with 0.1% Triton X-100 for 15 min,
followed by another wash in PBS and block in PBS containing 5% bovine serum albumin
(BSA) for 1 h. Primary and secondary antibodies in PBS containing 5% BSA were
applied overnight at 4 °C and 1 h at room temperature, respectively. Nuclei were
costained with 1 μg/ml Hoechst 33342. Fluorescence images were taken using a Nikon
Eclipse TE200 epifluorescence microscope with NIS-Elements AR3.2 software or EVOS
FL Auto (Life Technologies, Bothell, WA, USA). For manual quantification of the puncta
formation at least three optical fields with at least 50 cells per experimental condition
were analyzed. Data from repeated experiments were subjected to statistical analysis.
Electron microscopy. Electron microscopy was performed as described.42
Briefly, cells in 6-well plates were fixed in 2.5% glutaraldehyde (Sigma) in 0.1 M
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Figure 9 The working model of AMDE-1-induced canonical and noncanonical
LC3 lipidation. AMDE-1 is able to induce both canonical autophagy and NCA. The
ULK1 complex and the Beclin1–Atg14 complex are required in the canonical pathway,
but not in the noncanonical pathway. However, the LC3 conjugation system is
required in both pathways. While the phagophore provides the membrane platform for
LC3 lipidation in canonical autophagy, the Golgi complex is likely the membrane
platform for the noncanonical LC3 lipidation. Notably, the V-ATPase can have an
important role in the latter by acting at the Golgi complex, although the exact
molecular mechanism has yet to be determined. Thus, V-ATPase inhibitors, such as
Baf, can cause LC3-II accumulation because of blockage of autolysosome
degradation in canonical autophagy, but can cause LC3-II decrease because of
suppression of Golgi signaling at the early stage in NCA. Different agents can thus
affect the canonical and noncanonical pathways, which modulate the ultimate
outcomes for cells treated with chemicals with dual capability, such as AMDE-1
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phosphate buffer (pH 7.4) for 2 h, and then dehydrated in a graded ethanol series
and embedded. Ultrathin sections were mounted on copper grids. The samples
were then stained and visualized using a 120 kV Jeol electron microscope
(JEM-1400, Peabody, WA, USA) at 80 kV. Images were captured using a Gatan-
832 digital camera (Pleasanton, CA, USA).
Statistics. All experiments were performed at least in triplicate and data are
presented as mean±S.D. The statistical significance of data was verified by the
Student’s t-test wherever required. P-valueo0.05 was considered as being significant.
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